PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biological Defence Programme, DSO National Laboratories, Singapore, Singapore.\', \'Department of Microbiology & Immunology and Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, TX, United States of America.\', \'Hummingbird Bioscience, Singapore, Singapore.\', \'Life Science Institute, National University of Singapore, Singapore, Singapore.\', \'National Centre for Infectious Diseases, Singapore, Singapore.\', \'Singapore General Hospital, Singapore, Singapore.\', \'Programme in Emerging Infectious Disease, Duke-National University of Singapore Medical School, Singapore, Singapore.\', \'Department of Microbiology & Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.\', \'Experimental Drug Development Centre, Therapeutics Development, A*STAR Research Entities (ARES), Singapore, Singapore.\', \'Department of Microbiology & Immunology and Center of Biodefense and Emerging Disease, University of Texas Medical Branch, Galveston, TX, United States of America.\', \'Department of Pathology and Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0253487
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34161386
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34161386>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34161386>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all